Komori
Occurring Fact7459MEDIPAL HOLDINGS CORPORATIONTrading & Wholesale

Notice Regarding a Shareholder's Request to Convene an Extraordinary General Meeting of Shareholders

The Company has received a request from a shareholder that has held at least 3% of the voting rights for 6 months or more to convene an extraordinary general meeting of shareholders. The proposals include the dismissal of the representative director and president, an amendment to the Articles of Incorporation, a special dividend of ¥122 per share, and the acquisition of treasury shares for a total amount of up to ¥95 billion. The Company has not yet decided whether to convene the meeting or how to respond to the individual proposals.

Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
950
¥100 million (maximum total acquisition cost for the acquisition of treasury shares)
Wording
Avoiding a definitive answer
How definitive the wording is.

Notice Regarding a Shareholder's Request to Convene an Extraordinary General Meeting of Shareholders

Subject Entity

MEDIPAL HOLDINGS CORPORATION (requesting shareholder: The Northern Trust Company AVFC Re: Silchester International Investors International Value Equity Trust)

Occurrence2 September 2026 (date of preparation and submission of the request to convene an extraordinary general meeting of shareholders)
Same day
Awareness or receipt of notice2 September 2026 (the date the Company received the request)
This disclosure09/02/2026
Cause

The requesting shareholder cited excess capital accumulation, a low ROE, a low shareholder payout ratio, and management's disregard for shareholder requests, among other reasons. The Company's own explanation of the cause is Not disclosed.

Amount of Impact on Business Performance

The amount and accounting classification of the impact on the Company's results are Not disclosed. The request proposes a special dividend of ¥122 per share and the acquisition of treasury shares for a total amount of ¥95 billion.

Related procedures

Type

Request to convene an extraordinary general meeting of shareholders pursuant to Article 297, Paragraph 1 of the Companies Act

Company response

Directors' and officers' liability

The requesting shareholder has proposed, as Proposal No. 1, the dismissal of Director Watanabe Shuichi (渡辺秀一). Any reduction in remuneration, disciplinary action, resignation or other action by the Company is Not disclosed.

Outlook

The Company will carefully review the contents of the request and disclose its response policy once it has been decided. It also intends to continue dialogue with the requesting shareholder and its investment manager. The requesting shareholder is seeking the convening of an extraordinary general meeting of shareholders no later than 30 October 2026.

Planned follow-up disclosure

The Company will disclose its response policy once it has been decided. The specific disclosure date is Not disclosed.

Event that occurred
ItemDetails
Event nameNotice Regarding a Shareholder's Request to Convene an Extraordinary General Meeting of Shareholders
Date of occurrence2 September 2026 (date of preparation and submission of the request to convene an extraordinary general meeting of shareholders)
Date recognized / date notice received2 September 2026 (the date the Company received the request)
Subject EntityMEDIPAL HOLDINGS CORPORATION (requesting shareholder: The Northern Trust Company AVFC Re: Silchester International Investors International Value Equity Trust)
CauseThe requesting shareholder cited excess capital accumulation, a low ROE, a low shareholder payout ratio, and management's disregard for shareholder requests, among other reasons. The Company's own explanation of the cause is Not disclosed.
Amount of Impact on Business PerformanceThe amount and accounting classification of the impact on the Company's results are Not disclosed. The request proposes a special dividend of ¥122 per share and the acquisition of treasury shares for a total amount of ¥95 billion.
Type of litigation or proceedingRequest to convene an extraordinary general meeting of shareholders pursuant to Article 297, Paragraph 1 of the Companies Act
Directors' and officers' liabilityThe requesting shareholder has proposed, as Proposal No. 1, the dismissal of Director Watanabe Shuichi (渡辺秀一). Any reduction in remuneration, disciplinary action, resignation or other action by the Company is Not disclosed.
OutlookThe Company will carefully review the contents of the request and disclose its response policy once it has been decided. It also intends to continue dialogue with the requesting shareholder and its investment manager. The requesting shareholder is seeking the convening of an extraordinary general meeting of shareholders no later than 30 October 2026.
Planned follow-up disclosureThe Company will disclose its response policy once it has been decided. The specific disclosure date is Not disclosed.
Items this document does not state (15)
Target Locations / ProductsAccounting period in which recognizedImpact on Earnings ForecastCourt or authorityPlaintiffDefendantDate of filing / date of actionClaim amount / surcharge amountAmount of receivables at risk of non-collection or delayed collectionSuspended operationsScheduled resumption dateInvestigation structureMeasures to prevent recurrenceVoting rights ownership percentage before the changeVoting rights ownership percentage after the change

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The Company stated that it had received the request and would carefully review its contents before deciding and disclosing its response policy, but it did not explain the reasons for the request as reasons attributable to the Company itself. The requesting shareholder cited excess capital accumulation, low ROE, insufficient shareholder returns, and management's failure to submit shareholder proposals to the general meeting as reasons.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding a Shareholder's Request to Convene an Extraordinary General Meeting of Shareholders | MEDIPAL HOLDINGS CORPORATION (7459) timely disclosure | Komori